Physician profile
Alex Deyan
NPI 1083770622
$956.42
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $956.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $357.78 | 2019 | |
| Forte Bio-Pharma LLC | $105.13 | 2019 | |
| Vertical Pharmaceuticals, LLC | $83.35 | 2019 | |
| Therapeuticsmd, INC. | $73.00 | 2019 | |
| Allergan, INC. | $51.37 | 2019 | |
| Daiichi Sankyo INC. | $39.66 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.50 | 2019 | |
| Pfizer INC. | $35.01 | 2019 | |
| Hologic Sales and Service, LLC | $33.41 | 2019 | |
| Amgen INC. | $25.85 | 2019 | |
| Roche Diagnostics Corporation | $23.85 | 2019 | |
| Merck Sharp & Dohme LLC | $19.14 | 2019 | |
| Astellas Pharma US INC | $16.80 | 2019 | |
| Lupin INC. | $15.96 | 2019 | |
| Exeltis, USA INC. | $15.60 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $13.48 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $11.53 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Deyan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.